Equity Research, Broker Reports, and media content on VISTIN PHARMA AS

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about VISTIN PHARMA AS
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on VISTIN PHARMA AS. We currently have 0 research reports from 0 professional analysts.

Open
0.00
Volume
0.0m
Range
0.00/0.00
Market Cap
0m
52 Week
0.00/0.00
Date Source Announcement
09Oct17 13:33 GNW Vistin Pharma ASA : Proposal for Extraordinary Dividend
02Oct17 09:28 GNW Vistin Pharma ASA : Sale of Opioids and CMO business completed
31Aug17 06:00 GNW Vistin Pharma ASA : Second quarter 2017 results - continuing strong demand for metformin
11Jul17 11:04 GNW Vistin Pharma ASA : Vistin Pharma announces the sale of its Opioids and CMO business
28Feb17 06:00 GNW Vistin Pharma ASA : Fourth quarter and preliminary 2016 results
31Oct16 06:01 GNW Vistin Pharma ASA third quarter 2016: Investing in future growth
30Aug16 06:31 GNW Vistin Pharma ASA : Vistin Pharma to double its metformin production capacity by 2019 with MNOK 120 investment
  • Frequency of research reports

     

  • Research reports on

    VISTIN PHARMA AS

  • Providers covering

    VISTIN PHARMA AS